Allergan Doubles Down on Patent Abuse
Sixteen months ago the drug company Allergan sold the patent rights for Restasis, its popular prescription eyedrops, to the Saint Regis...
In Complementary Hearings, Senators and Representatives Vow To Tackle High Drug Prices
Yesterday, on January 29th, both houses of Congress focused on rising drug prices, responsibility for this unsustainable situation, and...
States Step Forward to Make Prescription Drugs More Affordable
At Families USA's Health Action Conference 2019, there were a number of excellent panels. But one of the best was a panel on state...
Drug Prices Take Center Stage At Families USA Conference
Skyrocketing prescription drug prices took central stage at Families USA's Health Action Conference 2019. Lawmakers, policy experts, and...
Boston News Channel Digs Into PBMs, And Where the Money Is Going
The Boston 25 News Channel is conducting a month long, in-depth investigation of pharmacy benefit managers (PBMs) and the role they play...
Secretary Alex Azar Raises Possibility of Bipartisan Cooperation on Lowering Drug Prices
Yesterday, Representative and new Chairman of the House Oversight and Government Reform Committee Elijah Cummings met with Secretary of...
New Coalition Forms to Lower Drug Prices By Fighting Patent Abuse
Consumer groups, patient advocacy organizations, employers, health care providers, free market advocates, and others launched a coalition...
How PBMs Are Hurting Independent Pharmacies in Maryland
Pharmacy benefit managers (PBMs) have a variety of negative impacts on our drug supply chain, and contribute to higher drug prices. But...
PBM Spread Pricing Leads to Much Higher Medicaid Drug Prices-But States Are Taking Action
Medicaid plans are paying wildly varying prices for generic drugs in different states. In some states, such as Arizona, Georgia,...
Incoming House Democrats Promise Stronger Antitrust Oversight
The 116th Congress has been sworn in, and House Democrats have declared they intend to have serious oversight of corporate monopolies and...
